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                                              Abstract 
 
Objective: to evaluate the diagnostic accuracies of well-known sonographic 
markers of adenomyosis and of two innovative ones, the question mark sign 
and the transvaginal ultrasound uterine tenderness. 
Methods: 78 patients scheduled for hysterectomy for uterine benign diseases 
underwent preoperative transvaginal ultrasonography to evaluate the criteria of 
sonographic diagnosis of adenomyosis as reported by consensus statement 
MUSA. Adenomyosis was diagnosed in presence of two or more of the 
following parameters: asymmetry of the uterine walls, hyperechoic striae, 
anechoic myometrial cysts, hyperechogenic islands, echogenic subendometrial 
lines and buds, interruption/irregularities of the junctional zone and 
translesional vascular flow. In addition the question mark sign and the 
transvaginal ultrasound uterine tenderness were evaluated, the first being the 
longitudinal section of the uterus with a morphology similar to a question mark 
and the other being the dynamic ultrasound evaluation of uterine tenderness by 
the pressure of the transvaginal probe. Sonographic features were compared 
with histological examination. 
Results: the prevalence of adenomyosis in the sample is 33.3%. Sensitivity, 
specificity, positive and negative predictive values and accuracy of transvaginal 
ultrasound in the diagnosis of adenomyosis are 83%, 96%, 91%, 89% and 92%. 
Asymmetry, hyperechoic striae and interruption of the junctional zone were the 
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most accurate markers for the diagnosis of adenomyosis. Myometrial 
heterogeneity was the most frequently encountered feature (100%), but showed 
a low specificity (7%). The question mark sign and the transvaginal ultrasound 
uterine tenderness showed sensitivity, specificity, positive and negative 
predictive values and accuracy of 41%, 96%, 83%, 77%, and 69% and 69%, 
65%, 66%, 81% and 67% respectively. 
Conclusions: the sonographic markers proposed by consensus statement 
MUSA were confirmed accurate in the diagnosis of adenomyosis in our sample. 
The question mark sign and the transvaginal ultrasound uterine tenderness 
showed good diagnostic capacities and may be a useful complement in the 
sonographic diagnosis of adenomyosis. 
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      Introduction 
 
 
Adenomyosis is a benign condition of the uterus defined by the presence of 
endometrial glands and stroma within the myometrium. Adenomyosis affects 
around 20% of women during their fertile age and may be associated to 
dysmenorrhea, menorrhagia and infertility1. 
A diagnosis of certainty can be posed only by histological examination. 
Several studies showed that transvaginal sonography (TVS) can be considered 
the first-line imaging modality for studying adenomyosis, because it is as 
sensitive and as specific as magnetic resonance,2–6 nevertheless univocal 
ultrasound parameters for the diagnosis of adenomyosis are still lacking.7 
Recently the MUSA (Morphological Uterus Sonographic Assessment) 
consensus statement proposed terms, definitions and measurements that may be 
used to describe and report the sonographic features of the myometrium using 
gray-scale sonography, color/power Doppler and three-dimensional ultrasound 
imaging, with particular regard to two conditions: adenomyosis and fibroids.8 
Even if many ultrasound features are supposed to be associated with 
adenomyosis, the diagnostic weight of each one is not clear and some features 
may be more relevant than others in order to formulate a diagnosis.8 A 
particular shape of the uterine rime, called the question mark sign, has been 
recently described as a typical sign of adenomyosis associated with deep 
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infiltrating posterior endometriosis9,10 and it was deliberately not included in 
the MUSA statement.8 Transvaginal ultrasound is a dynamic examination11, 
permitting to the operator to evaluate the tenderness of an examined anatomical 
structures by a gentle pressure of the probe. An enlarged and tender uterus, 
painful at mobilization may suggest adenomyosis12. The TVS uterine 
tenderness, that is the tenderness of the uterus during the gentle pressure with 
the transvaginal probe, could be useful to rule out the presence of adenomyosis, 
often associated to painful uterine mobilization. 
 The aim of our study is to establish the diagnostic accuracy of the 
ultrasound features associated to adenomyosis according to the MUSA 
statement and of two new markers, the question mark sign, evaluated 
independently from the presence of endometriosis, and the TVS uterine 
tenderness.
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                       Patients and methods 
 
 
This is a cross-sectional observational study enrolling all consecutive 
premenopausal women with a diagnosis of a benign uterine pathology, 
diagnosed by ultrasound or by hysteroscopy, and scheduled for hysterectomy 
from November 2014 to June 2016 in the Department of Gynaecology and 
Human Reproduction Pathophysiology, Sant’Orsola Hospital, University of 
Bologna. Postmenopausal women and those with a pre-surgical diagnosis of a 
reproductive tract cancer were excluded.  
 A data sheet with most relevant information on each patient’s medical 
history was filled in: age, BMI, last menstrual period, gravidity and parity, 
previous pelvic surgery, previous diagnosis of endometriosis, presence of 
dysmenorrhea, menorrhagia and dyspareunia. 
Transvaginal ultrasound examination was carried out using a 4–9-MHz probe 
with a three-dimensional (3D) facility (Voluson E8, GE Medical Systems, Zipf, 
Austria). All transvaginal ultrasound scans were performed in a standardized 
fashion by a single operator with more than 7 years of experience (L.Z.). 
Photos, clips and 3D scans were saved and stored for further examinations. The 
study of the uterine corpus was carried out as indicated by the MUSA 
statement.8 In addition the sonographer evaluated subjectively the globular-
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shape of the uterus, the tenderness of the uterus at the gentle pressure of the 
transvaginal probe and the presence of the question mark sign (Figure 1).9, 10 A 
3D volume of each uterus was stored following the method of Exacoustos13 in 
order to evaluate the junctional zone (JZ).8 The diagnosis of adenomyosis was 
posed when at least two of the ultrasound features studied were present.  
 Each patient underwent laparoscopic, laparotomic or vaginal 
hysterectomy according to her clinical condition within one month from the 
ultrasound examination. In each case the whole uterus was sent to histological 
examination, except one for which morcellation was needed. 
 All histopathological examinations were performed by the same 
pathologist, skilled in gynaecologic pathology and blinded to the ultrasound 
findings. For each uterus a series of samples were taken, including all the wall 
from the serosa to the endometrium. Of these, at least three samples were taken 
both from the posterior and from the anterior wall. The diagnosis of 
adenomyosis was posed if endometrial stroma and glands were present into the 
myometrial layer. Adenomyosis was reported as diffuse or focal and evaluated 
by the grade of invasion: limited to the internal half of the myometrium (M1) or 
full-thickness (M2). In case of doubt, an immunochemical test with CD10 
antibodies was performed in order to highlight the ectopical endometrium.14 For 
the purpose of this study, only the presence or absence of adenomyosis was 
considered, but not the depth of infiltration. 
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 All the data were recorded in an electronic database. Patients were 
divided into two groups, according to the presence or absence of adenomyosis 
at the histological examination. Means and standard deviations were calculated 
for the continuous variables, using the Student's T-test. Relative frequencies 
were calculated for the categorical variables using the chi-squared test or 
Fisher’s exact test. P value less than .05 was considered statistically significant. 
In order to compare gravidity and parity of the two groups, each one was 
divided into three classes, considering the number of pregnancies and 
deliveries. Agreement between TVS and histological diagnosis was measured 
with Cohen’s Kappa coefficient. Sensitivity, specificity, positive (PPV) and 
negative (NPV) predictive values, positive (LH+) and negative (LH-) likelihood 
ratios and accuracy (area under curve ROC) of each TVS variable were 
calculated. Analyses were performed by using the Statistical Package for the 
Social Sciences version 16 (SPSS Inc., Chicago, IL, USA). 
All the patients signed an informed consent and the study was approved by our 
local ethics committee (clinical trial ARC-ENDO n. 149/2014/O/Oss).
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                                                                   Results 
 
Seventynine patients were enrolled in this study and one was excluded because 
the uterus was morcellated during laparoscopic hysterectomy, due to its great 
size. The total number of patients considered in the statistical analysis is 78. 
Forty/78 (51.2%) patients were operated on for leyomyomatosis, 24/78 (30.8%) 
for adenomyosis, 10/78 (12.8%) for uterine prolapse, 4/78 (0.5%) for fibroids 
with atypical ultrasound appearance. Hysterectomy was performed through 
laparoscopy in 62/78 (79.5%) patients, laparotomy in 6/78 (7.7%) and vaginal 
approach in 10/78 (12.8%) cases. 
 Histology showed adenomyosis in 26/78 (33.3%) patients, among them 
16/26 (61.5%) presented fibroids and 6/26 (23.1%) presented adenomyomas. 
Among the 52/78 (66.6%) patients without adenomyosis 41/78 (52.5%) had 
fibroids, 1/78 (1.2%) had a spindle-like cells neoplasia with myogenic 
differentiation and mitotic index <4 M/10 HPF, and 10/78 (12.8%) showed 
hysterocele not associated to myometrial pathology. 
 Clinical features of patients are shown in Table 1. There are no 
statistically significant differences between the two groups with and without 
adenomyosis for age, BMI, gravidity and parity. Student's T-test and linear 
regression shows an inverse correlation between the uterine volume calculated 
by ultrasound and the diagnosis of adenomyosis. Nevertheless, by dividing the 
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two populations into quartiles of volumes, no statistically significant difference 
between the two groups can be found. 
 Percentage frequencies of symptoms and association with previous 
pelvic surgeries or with endometriosis are summarized in Table 2. All the 
diagnosis of endometriosis nodules suspected by TVS were confirmed by 
histology. Menorrhagia was significantly more frequent in patients with 
adenomyosis.  
 TVS diagnosed adenomyosis in 22/78 (28.2%) patients: in 20/22 
(90.9%) cases ultrasound diagnosis was confirmed by the pathologist, while 
2/22 (9.1%) cases were false positives. Among the 56/78 (71.8%) patients 
without ultrasound features of adenomyosis, 4/56 (7.1%) were false negatives, 
while 52/56 (92.9%) were true negatives. TVS diagnosed adenomyosis in 20/26 
(76.9%) patients positives at histological examination, with sensitivity, 
specificity, PPV, NPV 83%, 96%, 91% e 89% respectively. Positive and 
negative likelihood ratio were 20 and 0.24. Global accuracy of TVS is 92.3%. 
Kappa analysis showed a good accordance between histology and TVS 
(kappa=0.760). 
 Table 3 shows the statistical significance of each ultrasound feature 
included in the study according to presence/absence of adenomyosis at 
histology. Hyperechoic islands and subendometrial lines and buds were not 
present in the examined sample. Table 4 shows diagnostic capacities of each 
ultrasound marker. Heterogeneous myometrium showed the highest sensitivity 
and PPV (both 100%). Most specific markers were JZmax≥8mm, fan-shaped 
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striations and question-mark sign (respectively 99%, 96% and 96%), with PPV 
respectively 100%, 88% and 83%.  
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                                                          Discussion 
 
     This is the first study strictly applying the MUSA indications8 to 
prospectively validate the importance of each of these ultrasound features in the 
diagnosis of adenomyosis in a sample of 78 hysterectomies. In addition it 
showed two new ultrasound markers for the diagnosis of adenomyosis: the 
question mark sign and the TVS uterine tenderness, showing an accuracy of 
69% and 67% respectively.  
      In this study 2D, 3D and power Doppler ultrasound features were associated 
in order to diagnose adenomyosis, obtaining diagnostic capacities superior than 
Kepkep et al.15 and similar to those obtained in other studies, which report 
sensitivity up to 89% and specificity up to 100%.16-18 In accordance with Bazot 
et al.18 TVS is very specific, but prone to produce false negatives, which is the 
best condition for a test aiming to diagnose a benign pathology. In addition, our 
data show that TVS diagnostic capacity is reduced in the presence of 
comorbidities, as it was already demonstrated 3,18: all the diagnostic mistakes (4 
false negatives, 2 false positives) were made in patients affected by fibroids. A 
recent meta-analysis of 14 trials and 1985 participants reported sensitivity and 
specificity of ultrasound-diagnosed adenomyosis to be as high as 82.5 and 
84.6%, respectively19. Our data showed a similar sensitivity but a greater 
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specificity, maybe due to the presence of two new sonographic markers of 
endometriosis. 
      The question mark sign has been recently proposed by our group as a 
marker of adenomyosis strongly associated with deep infiltrating posterior 
endometriosis.10 In the present study the question mark sign showed to be a 
marker of adenomyosis independent from the presence of endometriosis. Its 
strong association with adenomyosis is in contrast with MUSA consensus 
statement.8 The question mark sign showed also great specificity (96%) and 
PPV (83%) with the best positive likelihood ratio among 2D ultrasound features. 
In this sample, only 4 out of the ten patients affected by deep infiltrating 
posterior endometriosis showed an associated question mark sign and Fisher’s 
exact test excluded a correlation (p=0.245). These results suggest that question 
mark sign might have a wider application in diagnosing adenomyosis than 
previously thought.  
     As far as we are aware this is the first prospective study proposing TVS 
uterine tenderness as a marker of adenomyosis, showing a NPV of 81% and an 
accuracy of 67.3%. Original descriptions of adenomyosis reported an 
association between the disease and “a great deal of pain”20. Several later 
studies reported similar findings21-23, but others have not shown significant 
differences in the prevalence of adenomyosis in women with and without a 
history of pain24-26. One possible confounder in the interpretation of pain could 
be the coexisting presence of endometriosis, which is a common cause of pain 
in women of reproductive age. We believe that the use of TVS, as a dynamic 
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examination11, permits to show if the pain is related to the gentle pressure and 
mobilization of the uterus and permits as well to find the tenderness related to 
other location of endometriosis, if present. 
        Among the ultrasound features of adenomyosis the most specific were 
JZmax≥8mm, fan-shaped striations and question-marked sign. Our results are 
comparable to previous studies for the high specificity of fan-shaped striation15-
18
 and of myometrial cysts27, while Jzmax in our study showed better values 
than previously shown27. Heterogeneous myometrium is once again the most 
sensitive marker, but with very low specificity18. The main problem with the 
use of histology for the diagnosis of adenomyosis is the heavy selection bias 
incurred28, indeed we had a very high percentage of leyomyomatosis, typically 
associated to heterogeneous myometrium at TVS. 
    Prevalence of adenomyosis in the sample is 33.3%, which is consistent with 
the Literature, where a mean value of 20-30% is reported in patients undergoing 
hysterectomy for various indications29-31. 
       Differently from Literature5,6,8 an association between increased uterine 
volume and adenomyosis was not found. Regarding this, it should be taken into 
account that patients without adenomyosis were often affected by 
leyomyomatosis, which also increases uterine volume. Nevertheless, 
Exacoustos et al. demonstrated a significant correlation between decreased 
uterine volume and adenomyosis, in comparison with uterus without fibroids13.  
     Several strengths add power to this study: the use of histological 
confirmation of the diagnosis, the fact that all ultrasound scans were performed 
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using top-of-the-range equipment by a single operator, thereby minimizing 
interobserver variability and the fact that all the demographic, ultrasound and 
anamnestic data were collected prospectively. In particular it is remarkable that 
all the diagnosis of endometriotic nodules suspected by TVS were confirmed by 
histology. Moreover the choice of using wide inclusion criteria reduced the 
selection bias and allowed to evaluate adenomyosis in presence of numerous 
potentially confounding variables, as fibroids, that often reduce diagnostic 
accuracy3,18.  Wide inclusion criteria are also a potential weakness of this study, 
as confounding factors, such as fibroids and hormonal treatments prevented 
some features from being detectable in several patients. Another main 
limitation of this study is the only inclusion of patients undergoing 
hysterectomy, creating a selection bias, as patients who chose surgery are more 
symptomatic than those who do not. 
    This study confirms TVS diagnostic accuracy in diagnosing adenomyosis, 
reinforcing TVS role as a first-line exam for its reliability, safety and cheapness. 
Comparing the ultrasound features considered currently to be typical of 
adenomyosis in a sample full of confounding factors demonstrates their validity 
even in less selected patients, providing an updated and realistic idea of TVS 
diagnostic capacities that could be applied in everyday clinical practice. The 
two new proposed features, the question mark sign and the TVS uterine 
tenderness, showed promising results and might prove to be useful for the 
diagnosis of adenomyosis. Further prospective studies are needed in order to 
prove their efficacy in wider samples.  
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Table 1. Population characteristic of 78 premenopausal patients according to 
presence/absence of adenomyosis at histology. Data are presented as mean ± 
standard deviation, or as % frequencies.  
                                         Adenomyosis at histology  
Characteristic Yes (n=26) No (n=52) P 
 
 
Age (years) 
 
48.2 ± 3.9 
 
47.1 ± 3.9 
 
n.s. 
BMI 24.6 ± 1.1 25.5 ± 1.0 n.s. 
Parity   
0 38.5% 23.1% n.s. 
1 23.1% 30.8% n.s. 
>1 38.4% 46.1% n.s. 
Gravidity   
0 30.8% 19.2% n.s. 
1 23.1% 26.9% n.s. 
>1 46.1% 53.9% n.s. 
Uterine volume 230 ± 189 295 ± 306 n.s. 
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Table 2. Clinical symptoms and association with previous pelvic surgeries and 
endometriosis according to presence/absence of adenomyosis at histology. Data 
are presented as frequencies.   
 
                                                          Adenomyosis at histology  
 
Yes (n=26) No (n=52) P 
 
   
Dysmenorrhea 77% 50% n.s. 
Dyspareunia 46% 31% n.s. 
Menorrhagia 85% 50% 0.045 
Previous pelvic surgery 46% 46% n.s. 
Presence of endometriosis 30% 15% n.s. 
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Table 3. Ultrasound features according to presence/absence of adenomyosis at 
histology.  Data are presented as n(%). N.e. not evaluable. 
                                                               Adenomyosis at histology  
Features Yes (n=26) No (n=52) N.e. P 
 
Globular shape 
 
 
10 (77%) 
 
14 (54%) 
 
0 
 
n.s. 
Heterogeneus myometrium  
 
13 (100%) 
 
24 (92%) 
 
0 n.s. 
Fan-shaped striations 
 
7 (54%) 1 (4%) 
 
0 0.001 
Myometrial cysts 
 
4 (31%) 2 (8%) 0 n.s. 
Ill-defined interface 11 (85%) 
 
11 (42%) 
 
1 0.037 
Question mark sign 
 
5 (38%) 
 
1 (4%) 
 
2 0.005 
Walls asymmetry 
 
8 (62%) 
 
2 (8%) 
 
20 0.001 
TVS uterine tenderness 
 
9 (69%) 
 
9 (35%) 
 
0 0.044 
Doppler 
 
4 (31%) 
 
2 (8%) 
 
2 0.011 
JZ max ≥ 8 mm 
 
4 (31%) 
 
0 (0%) 
 
13 0.015 
∆ JZ ≥ 4 mm 
 
6 (46%) 
 
2 (8%) 
 
13 0.027 
JZ interruption 
 
7 (54%) 
 
2 (8%) 
 
13 0.008 
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Table 4. Diagnostic capacities of each ultrasound features associated to the 
diagnosis of adenomyosis. 
 
Feature Sensibility Specificity PPV NPV LR+ LR- Accuracy 
        
Globular shape 
 
77% 46% 42% 80% 1.43 0.5 61.5% 
Asimmetry 
 
80% 70% 72% 78% 2.67 0.29 78.9% 
Heterogeneous myometrium 
 
100% 7% 35% 100% 1.08 0 53.9% 
Ill-defined interface 
 
85% 56% 50% 88% 1.9 0.27 70.3% 
Fan-shaped striations 
 
54% 96% 88% 81% 14 0.48 75.0% 
Myometrial cysts 
 
30% 92% 67% 73% 4 0.75 61.5% 
Question-mark sign 
 
41% 96% 83% 77% 10.42 0.61 68.8% 
TVS uterine tenderness 
 
69% 65% 66% 81% 2 0.47 67.3% 
JZ max 
 
40% 99% 100% 73% 4 0.60 70.0% 
JZ interruption 
 
70% 88% 78% 82% 5.64 0.35 78.8% 
∂JZ 
 
60% 87% 75% 76% 4.5 0.46 73.8% 
Doppler 
 
55% 88% 66% 82% 4.72 0.51 71.5% 
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Figure 1. Transvaginal sonography longitudinal section of a uterus showing the 
question mark sign which is described when the corpus uteri is flexed 
backwards, the fundus uteri is facing the posterior pelvic compartment and the 
cervix is directed frontally towards the urinary bladder with the endometrial 
rhim resembling a question mark sign (a, b). Schematic drawing of the question 
mark sign (c). 
 
 
 
 
 
a 
 
 
c 
 
 
b 
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